C

Cigna Group
SWB:CGN

Watchlist Manager
Cigna Group
SWB:CGN
Watchlist
Price: 251.1 EUR 7.68% Market Closed
Market Cap: €47B

Wall St Price Targets

CGN Price Targets Summary
Cigna Group

Wall Street analysts forecast CGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGN is 299.73 EUR with a low forecast of 254.07 EUR and a high forecast of 364.32 EUR.

Lowest Forecast
Price Target
254.07 EUR
1% Upside
Average Forecast
Price Target
299.73 EUR
19% Upside
Highest Forecast
Price Target
364.32 EUR
45% Upside
Cigna Group Competitors:
Price Targets
SIGI
Selective Insurance Group Inc
-2% Downside
ALG
Alamo Group Inc
25% Upside
APO
Apollo Global Management Inc
29% Upside
BMRN
Biomarin Pharmaceutical Inc
54% Upside
SRFM
Surf Air Mobility Inc
501% Upside

Revenue
Forecast

20% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
20% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 6%.

Gross Profit
Forecast

8% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is -2%.

Operating Income
Forecast

13% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
13% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.

Pre-Tax Income
Forecast

11% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
11% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 13%.

Net Income
Forecast

12% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
12% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CGN's stock price target?
Price Target
299.73 EUR

According to Wall Street analysts, the average 1-year price target for CGN is 299.73 EUR with a low forecast of 254.07 EUR and a high forecast of 364.32 EUR.

What is the Revenue forecast for Cigna Group?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 6%.

What is the Gross Profit forecast for Cigna Group?
Projected CAGR
-2%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is -2%.

What is the Operating Income forecast for Cigna Group?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.

What is the Pre-Tax Income forecast for Cigna Group?
Projected CAGR
13%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for Cigna Group?
Projected CAGR
16%

Over the last 14 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett